William Hawkins

William Hawkins General Information

Description

Mr. William Hawkins serves as Board Member & Member of the Compensation and Management Development Committee at Biogen. He serves as Board Advisor at HealthQuest Capital. He served as Board Member at Cereius. He has served as a member of our Board since September 2020 and as Chairperson of our Board since September 2020. He also serves as a Member of the Advisory Board at FCA Health Innovations. Mr. William served as Board Member at AskBio. He is a Senior Advisor to EW Healthcare Partners, a leading private equity firm investing in life sciences. From October 2011 to July 2015, He served as Chief Executive Officer of Immucor, Inc., a leading provider of transfusion and transplantation diagnostic products worldwide. Prior to that, He served in positions of increasing responsibility at Medtronic, Inc., a prominent medical technology company, from January 2002 to June 2011, most recently serving as its Chief Executive Officer from November 2007 to June 2011. He served as President and Chief Executive Officer of Novoste Corporation, a global leader in the field of vascular brachytherapy, from 1988 to 2002 and has also held several senior leadership positions at American Home Products (now known as Wyeth, LLC), Johnson & Johnson, Guidant Corp. and Eli Lilly and Co. He has served as a member of the board of managers of BV LLC since January 2016. He also currently serves on the board of directors of MiMedx Group Inc., each a public biopharmaceutical company; and Baebies, Inc., Cirtec Medical Corp., and Virtue Labs, LLC, each a privately-held life science company. He serves on the ethics and compliance committee of MiMedx. He was elected to the Duke University Board of Trustees in 2011 and currently serves as its Vice Chairman. He is also Chair of the Duke University Health System board of director and a member of the board of directors of the North Carolina Biotechnology Center and the Focused Ultrasound Foundation Society.He holds a Master of Business Administration from the University of Virginia Darden School of Business and received a Bachelor of Science in electrical and biomedical engineering from Duke University. He was selected to serve on our Board because of his experience in and knowledge of the life science industry.